Search

Your search keyword '"Felker, G"' showing total 271 results

Search Constraints

Start Over You searched for: Author "Felker, G" Remove constraint Author: "Felker, G" Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
271 results on '"Felker, G"'

Search Results

2. Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study

4. Comparing Analytical Methods for Composite End Points in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure With Reduced Ejection Fraction Trial

5. The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF

6. Serum Proteomic Analysis of Peripartum Cardiomyopathy Reveals Distinctive Dysregulation of Inflammatory and Cholesterol Metabolism Pathways

10. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society

14. Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel

22. Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT study

25. The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial

27. Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF

28. Intercountry Differences in Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure

32. Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

33. Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study

38. Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2

39. Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel

41. Splanchnic Nerve Block for Chronic Heart Failure

42. Endpoints in Heart Failure Drug Development: History and Future

48. Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF

Catalog

Books, media, physical & digital resources